EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibiting miR-200a-3p Increases Sirtuin 1 and Mitigates Kidney Injury in a Tubular Cell Model of Diabetes and Hypertension-Related Renal Damage

Olga Martinez-Arroyo iD, Ana Flores-Chova, Marta Mendez-Debaets, Laia Garcia-Ferran iD, Lesley Escrivá iD, Maria Jose Forner iD, Josep Redón iD, Raquel Cortes iD, Ana Ortega iD

Biomolecules · 2025

DOI: 10.3390/biom15070995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Olga Martinez-Arroyo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiometabolic and Renal Risk Research Group, Biomedical Research Institute of Hospital Clinico de Valencia INCLIVA, 46010 Valencia, Spain. Hauptthemen laut MEDLINE: Sirtuin 1, MicroRNAs, Kidney Tubules, Hypertension. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro de Investigación en Red en Enfermedades Cardiovasculares, European Regional Development Fund, Carlos III Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension and diabetes mellitus are key contributors to kidney damage, with the renal tubule playing a central role in the progression of kidney disease. MicroRNAs have important regulatory roles in renal injury and are among the most abundant cargos within extracellular vesicles (EVs), emerging as novel kidney disease biomarkers and therapeutic tools. Previously, we identified miR-200a-3p and its target SIRT1 as having a potential role in kidney injury. We aimed to evaluate miR-200a-3p levels in EVs from patient’s urine and delve into its function in causing tubular injury. We quantified miR-200a-3p urinary EV levels in hypertensive patients with and without diabetes (n = 69), 42 of which were with increased urinary albumin excretion (UAE). We analysed miR-200a-3p levels in EVs and cellular pellets, as well as their targets at mRNA and protein levels in renal tubule cells (RPTECs) subjected to high glucose and Angiotensin II treatments, and observed their influence on apoptosis, RPTEC markers and tubular injury markers. We conducted microRNA mimic and inhibitor transfections in treated RPTECs. Our findings revealed elevated miR-200a-3p levels in increased UAE patient urinary EVs, effectively discriminating UAE (AUC of 0.75, p = 0.003). In vitro, miR-200a-3p and renal injury markers increased, while RPTEC markers, SIRT1, and apoptosis decreased under treatments. Experiments using miR-200a-3p mimics and inhibitors revealed a significant impact on SIRT1 and decrease in tubular damage through miR-200a-3p inhibition. Increased levels of miR-200a-3p emerge as a potential disease marker, and its inhibition provides a therapeutic target aimed at reducing renal tubular damage linked to hypertension and diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 1MicroRNAsKidney TubulesHypertensionDiabetes MellitusHumansMaleFemaleMiddle AgedExtracellular VesiclesApoptosisDiabetic NephropathiesBiomarkersAgedCell Line

Stichwörter der Autor:innen

Sirtuin 1biomarkerextracellular vesiclesmiR-200a-3prenal damagetubular injury

Substanzen

Sirtuin 1MicroRNAsMIRN200 microRNA, humanSIRT1 protein, humanBiomarkers

Autor:innen und Institutionen

  • Cardiometabolic and Renal Risk Research Group, Biomedical Research Institute of Hospital Clinico de Valencia INCLIVA, 46010 Valencia, Spain.
  • Internal Medicine Unit, Hospital Clinico Universitario, 46010 Valencia, Spain.
  • Department of Medicine, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
  • CIBEROBN (CIBER of Obesity and Nutrition Physiopathology), Carlos III Health Institute), 28029 Madrid, Spain.
  • CIBERCV (CIBER of Cardiovascular Diseases), Carlos III Health Institute, 28029 Madrid, Spain.

ORCID-Profile: Olga Martinez-Arroyo, Laia Garcia-Ferran, Lesley Escrivá, Maria Jose Forner, Josep Redón, Raquel Cortes, Ana Ortega

Förderung

  • Centro de Investigación en Red en Enfermedades Cardiovasculares
  • European Regional Development Fund
  • Carlos III Health Institute
  • Ministerio de Ciencia, Innovación y Universidades
  • Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition
  • Juan de la Cierva Incorporación contract
  • Ayudas consolidación Investigadora
  • MCIN/AEI/10.13039/501100011033

Zitieren

APA

Martinez-Arroyo, O., Flores-Chova, A., Mendez-Debaets, M., Garcia-Ferran, L., Escrivá, L., Forner, M. J., Redón, J., Cortes, R., & Ortega, A. (2025). Inhibiting miR-200a-3p Increases Sirtuin 1 and Mitigates Kidney Injury in a Tubular Cell Model of Diabetes and Hypertension-Related Renal Damage. Biomolecules. https://doi.org/10.3390/biom15070995

Vancouver

Martinez-Arroyo O, Flores-Chova A, Mendez-Debaets M, Garcia-Ferran L, Escrivá L, Forner MJ, et al. Inhibiting miR-200a-3p Increases Sirtuin 1 and Mitigates Kidney Injury in a Tubular Cell Model of Diabetes and Hypertension-Related Renal Damage. Biomolecules. 2025. doi:10.3390/biom15070995

BibTeX
@article{MartinezArroyo2025,
  author = {Martinez-Arroyo, Olga and Flores-Chova, Ana and Mendez-Debaets, Marta and Garcia-Ferran, Laia and Escrivá, Lesley and Forner, Maria Jose and Redón, Josep and Cortes, Raquel and Ortega, Ana},
  title = {Inhibiting miR-200a-3p Increases Sirtuin 1 and Mitigates Kidney Injury in a Tubular Cell Model of Diabetes and Hypertension-Related Renal Damage},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15070995}
}
Kostenlos starten →